Get started
Author

Katherine Heath

Observed names: Heath, Katherine, Heath, Katherine Valerie, K Heath, K V Heath, K. Heath, K. V. Heath, Katherine V Heath, Katherine V. Heath, Katherine V. Heath,, Katherine V. Heath, Katie Heath
Institution: Burnet Institute
Observed institutions: University of British Columbia, Burnet Institute, University of Liverpool, St. Paul's Hospital, University of Oxford, World Health Organization, Chelsea and Westminster Hospital, BC Centre for Excellence in HIV/AIDS, Imperial College London
ORCID: 0000-0002-4752-9732
Observed ORCID: 0000-0002-4752-9732
OpenAlex ID: A5073730796
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
2002 · Robert S. Hogg, Katherine Heath, et al. · AIDS · 425
Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response
2015 · Bryony Simmons, Jawaad Saleem, et al. · Clinical Infectious Diseases · 261
PDF
Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database
2001 · Katherine V. Heath, Robert S. Hogg, et al. · AIDS · 249
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
2003 · Kevin J P Craib, Patricia M Spittal, et al. · PubMed · 210
The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study
2013 · Bohdan Nosyk, Julio S G Montaner, et al. · The Lancet Infectious Diseases · 206
The Joint United Nations Programme on HIV/AIDS 95–95–95 targets: worldwide clinical and cost benefits of generic manufacture
2021 · Katherine Heath, Jacob Levi, et al. · AIDS · 148
Antiretroviral Treatment Patterns and Incident HIV-Associated Morphologic and Lipid Abnormalities in a Population-Based Cohort
2002 · Katherine V. Heath, Robert S. Hogg, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 97
Intentional Nonadherence Due to Adverse Symptoms Associated With Antiretroviral Therapy
2002 · Katherine V. Heath, Joel Singer, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 96
Modelling the impact of relaxing COVID ‐19 control measures during a period of low viral transmission
2020 · Nick Scott, Anna Palmer, et al. · The Medical Journal of Australia · 88
PDF
Minimum costs to manufacture new treatments for COVID-19
2020 · Andrew Hill, Junzheng Wang, et al. · Journal of Virus Eradication · 81
PDF
Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy
2002 · Katherine V Heath, Keith J Chan, et al. · International Journal of Epidemiology · 63
Highly Active Antiretroviral Therapy: Physician Experience and Enhanced Adherence to Prescription Refill
2003 · Juan Delgado, Katherine V Heath, et al. · Antiviral Therapy · 60
PDF
Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada
2013 · Bohdan Nosyk, Guillaume Colley, et al. · PLoS ONE · 55
PDF
Determinants of Complementary Therapy Use in HIV-Infected Individuals Receiving Antiretroviral or Anti-opportunistic Agents
1997 · Michelle J. Ostrow, Peter G.A. Cornelisse, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 53
Disparities in the Burden of HIV/AIDS in Canada
2012 · Robert S. Hogg, Katherine Heath, et al. · PLoS ONE · 43
PDF
Antiretroviral Resistance among HIV‐Infected Persons Who Have Died in British Columbia, in the Era of Modern Antiretroviral Therapy
2004 · Magdalena A. Recsky, Zabrina L. Brumme, et al. · The Journal of Infectious Diseases · 39
WHO hepatitis C elimination targets: the global equity challenge
2024 · Katherine Heath, Andrew Hill · ˜The œLancet. Gastroenterology & hepatology · 38
Most new HIV infections, vertical transmissions and AIDS-related deaths occur in lower-prevalence countries
2019 · Joe Kempton, Andrew Hill, et al. · Journal of Virus Eradication · 37
PDF
Emerging Drug Toxicities of Highly Active Antiretroviral Therapy for HumanImmunodeficiency Virus (HIV) Infection
2003 · K. Heath, J. Montaner, et al. · Current Drug Targets · 33
HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men
1999 · Katherine V. Heath, Peter G. A. Cornelisse, et al. · International Journal of STD & AIDS · 32
Correlates of Suicide Attempts in an Open Cohort of Young Men Who Have Sex with Men
2002 · Michael R. Botnick, Katherine V. Heath, et al. · Canadian Journal of Public Health · 30
PDF
Treatment Interruption of Highly Active Antiretroviral Therapy in Patients with Nadir CD4 Cell Counts >200 Cells/mm3
2005 · Adrienne R. Toulson, Richard Harrigan, et al. · The Journal of Infectious Diseases · 29
Recruiting and retaining community-based participants in a COVID-19 longitudinal cohort and social networks study: lessons from Victoria, Australia
2023 · Thi Nguyen, Alexander J. Thomas, et al. · BMC Medical Research Methodology · 25
PDF
WHO method for estimating congenital syphilis to inform surveillance and service provision, Paraguay
2022 · Katherine Heath, Monica Alonso, et al. · Bulletin of the World Health Organization · 19
PDF
Total Lymphocyte Count as a Possible Surrogate of Cd4 Cell Count to Prioritize Eligibility for Antiretroviral Therapy among HIV-Infected Individuals in Resource-Limited Settings
2003 · Richard Bedell, Katherine V Heath, et al. · Antiviral Therapy · 18
PDF
Works count: 74
Citation count: 2,638
H-index: 23
I10-index: 35
Year
Topic
Type